Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options
Abstract Background Being the standard-of-care for four decades, cisplatin-based chemotherapy is highly efficient in treating germ cell tumors (GCT). However, often refractory patients present with a remaining (resistant) yolk-sac tumor (YST(-R)) component, resulting in poor prognosis due to lack of...
Saved in:
Main Authors: | Margaretha A. Skowron (Author), Mara Kotthoff (Author), Felix Bremmer (Author), Katja Ruhnke (Author), Fatma Parmaksiz (Author), Annika Richter (Author), Stefan Küffer (Author), Kirsten Reuter-Jessen (Author), Stella Pauls (Author), Anja Stefanski (Author), Philipp Ströbel (Author), Kai Stühler (Author), Daniel Nettersheim (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pure yolk sac tumor of sacrococcygeal region
by: Rashim Sharma, et al.
Published: (2021) -
A sinonasal yolk sac tumor in an adult
by: Jaehoon Shin, et al.
Published: (2022) -
Bilateral ovarian yolk sac tumor in adolescent
by: Yisel González Ríos, et al.
Published: (2023) -
Cases of Yolk sac tumor associated with gynecological malignant tumor
by: Shengchao Wang, et al.
Published: (2023) -
Post-menopausal presentation of yolk sac germ cell tumour
by: V.L. Parker, et al.
Published: (2015)